dc.contributor.author | Yazici, Y | |
dc.contributor.author | Yazici, H | |
dc.date.accessioned | 2021-03-03T08:52:48Z | |
dc.date.available | 2021-03-03T08:52:48Z | |
dc.identifier.citation | Yazici Y., Yazici H., "Adverse events (AE) are inadequately reported in randomized controlled trials (RCT) of TNF alpha and COX-2 inhibitors.", 69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 12 - 17 Kasım 2005, cilt.52 | |
dc.identifier.other | av_1a08142a-b825-4fad-b5d9-3025056eb4f1 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/22771 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | Adverse events (AE) are inadequately reported in randomized controlled trials (RCT) of TNF alpha and COX-2 inhibitors. | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 52 | |
dc.contributor.firstauthorID | 131239 | |